Brittany Bradrick insider trades
Open-market stock purchases and sales by Brittany Bradrick, Director at Dermata Therapeutics, Inc, from SEC Form 4 filings since Jan 12, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 2, 2026 | DRMA Dermata Therapeutics, Inc | Bought (not open market) | — |